Cargando…
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
Since its discovery, small interfering RNA (siRNA) has been considered a potent tool for modulating gene expression. It has the ability to specifically target proteins via selective degradation of messenger RNA (mRNA) not easily accessed by conventional drugs. Hence, RNA interference (RNAi) therapeu...
Autores principales: | Khaja, Fatima, Jayawardena, Dulari, Kuzmis, Antonina, Önyüksel, Hayat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302539/ https://www.ncbi.nlm.nih.gov/pubmed/28344266 http://dx.doi.org/10.3390/nano6010008 |
Ejemplares similares
-
Nanoparticulate paclitaxel loaded into sterically stabilized mixed phospholipid micelles to improve chemotherapy of breast cancer
por: Rubinstein, I, et al.
Publicado: (2005) -
Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
por: Lee, Kyungwoo, et al.
Publicado: (2020) -
Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022) -
Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations
por: Sahib, Mohanad Naji, et al.
Publicado: (2012) -
Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
por: Zhou, Yutong, et al.
Publicado: (2020)